Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 15/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | RBP4 | P02753 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31728001 | 0.91 | NPC1 (0.31) | SMN1; SMN2CHRNB4CHRNA3 | |
| SCHEMBL31727985 | 0.82 | PDE10A (0.38) | OPRK1KMT2A | |
| SCHEMBL31727266 | 0.82 | OPRK1 (0.34) | OPRK1MEN1KMT2A | |
| SCHEMBL31728267 | 0.82 | OPRK1 (0.34) | OPRK1MEN1KMT2A | |
| SCHEMBL31727781 | 0.81 | OPRK1 (0.37) | OPRK1RBP4 | |
| SCHEMBL31727588 | 0.79 | MAPT (0.36) | OPRK1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL31728093 | 0.79 | CHRNB4 (0.41) | OPRK1CHRNB4CHRNA3 | |
| SCHEMBL31727072 | 0.77 | MAPT (0.39) | OPRK1CHRNB4CHRNA3MEN1KMT2A | |
| SCHEMBL31727915 | 0.77 | HRH4 (0.31) | OPRK1 | |
| SCHEMBL31727323 | 0.76 | LMNA (0.40) | OPRK1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025231561-A1 | TERTIARY AMINE-SUBSTITUTED BIPYRIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND THEIR USE AS PHARMACEUTICALS | UNIVERSITE DE MONTREAL (CA) | 2025-11-13 | — | — | WO | disclosed |